Company Valuation: Core Scientific, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 3,924 4,514 4,820 - -
Change - 15.06% 6.77% - -
Enterprise Value (EV) 1 3,087 5,279 8,068 11,733 15,704
Change - 71.04% 52.82% 45.44% 33.84%
P/E -3.2x -16.5x -3.59x 82.6x 32.4x
PBR -5.01x -4.75x -2.16x -2.43x -3.02x
PEG -0x 0.2x -0x -1x 0x
Capitalization / Revenue 7.68x 14.2x 7.13x 4.2x 2.79x
EV / Revenue 6.04x 16.5x 11.9x 10.2x 9.1x
EV / EBITDA 19.6x -178x 35.6x 18.8x 14.5x
EV / EBIT -161x -21.5x -26.3x 32x 23.5x
EV / FCF -59.3x -11.7x -8.62x -3.23x -2.94x
FCF Yield -1.69% -8.54% -11.6% -31% -34%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -4.39 -0.88 -4.174 0.1816 0.4626
Distribution rate - - - - -
Net sales 1 510.7 319 675.6 1,148 1,725
EBITDA 1 157.4 -29.66 226.3 625.7 1,082
EBIT 1 -19.2 -245.6 -307.2 367 668.3
Net income 1 -1,315 -288.6 -1,508 78.56 198.4
Net Debt 1 -837 764.7 3,248 6,913 10,884
Reference price 2 14.05 14.56 15.00 15.00 15.00
Nbr of stocks (in thousands) 279,253 310,061 321,340 - -
Announcement Date 2/26/25 3/2/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-3.59x11.94x35.64x-.--% 4.82B
-58.34x7.25x31.93x-.--% 42.83B
-1.01x - - - 13.3B
-15x12.52x19.29x-.--% 11.36B
-13.38x40.54x-44.82x - 8.56B
-4.18x44.61x303.88x - 6.7B
-14.89x16.33x48.21x - 6.17B
-5.2x8.74x-26.1x-.--% 5.42B
-6.71x - - -.--% 4.36B
-6.74x34.19x-249.13x-.--% 3.68B
Average -12.90x 22.02x 14.86x 0% 10.72B
Weighted average by Cap. -28.14x 15.97x 29.58x 0%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Core Scientific, Inc.

Historical PBR trend

Valuation ratios - PBR - Core Scientific, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Core Scientific, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Core Scientific, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Core Scientific, Inc.
  1. Stock Market
  2. Stocks
  3. CORZ Stock
  4. Valuation Core Scientific, Inc.